Clinical Trial Data Comparing Bronchial Blockers for Thoracoscopic Lobectomy

80 patients were enrolled in a randomized controlled trial at Nanpi People’s Hospital comparing a double-cuff bronchial blocker (DcBB) to a single-cuff bronchial blocker (ScBB) during thoracoscopic lobectomy for lung cancer. The dataset likely contains primary and secondary outcomes including malposition incidence, placement time, surgical duration, and adverse events. Author Guoliang Tang published the data on figshare under a CC-BY-4.0 license in May 2026.

Use Cases

• Compare device performance based on malposition incidence data mentioned in the description
• Analyze surgical procedure times based on secondary outcome variables
• Evaluate patient safety based on adverse cardiovascular event rates
• Model device placement stability based on lung collapse grades

Strengths

• Data from a randomized controlled clinical trial with 80 patients
• Includes multiple measured outcomes such as malposition incidence (7.5% vs 30%) and placement time (32.28 ± 5.37 sec vs 19.90 ± 4.16 sec)
• Registered trial (ChiCTR2400086472) providing provenance

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Data is from a single-center study (Nanpi People’s Hospital), which may limit generalizability

Provenance

Source

figshare

Collection Method

Single-center randomized controlled clinical trial

Freshness

Last updated 2026-05-21 17:35:23; freshness should be verified

Geography

Nanpi People’s Hospital